Search Results - "Lorf, Thomas"

Refine Results
  1. 1

    Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients by Obed, Aiman, Stern, Steffen, Jarrad, Anwar, Lorf, Thomas

    Published in World journal of gastroenterology : WJG (14-04-2015)
    “…Alcoholic liver disease(ALD) is the second most common diagnosis among patients undergoing liver transplantation(LT).The recovery results of patients…”
    Get full text
    Journal Article
  2. 2

    Interleukin 2 receptor antagonists for liver transplant recipients: A systematic review and meta‐analysis of controlled studies by Goralczyk, Armin D., Hauke, Nicola, Bari, Narin, Y. Tsui, Tung, Lorf, Thomas, Obed, Aiman

    Published in Hepatology (Baltimore, Md.) (01-08-2011)
    “…Interleukin 2 receptor antagonists (IL‐2Ra) are frequently used as induction therapy in liver transplant recipients to decrease the risk of acute rejection…”
    Get full text
    Journal Article
  3. 3

    Perioperative LiMAx Test Analysis: Impact of Portal Vein Embolisation, Chemotherapy and Major Liver Resection by Rühlmann, Felix, Azizian, Azadeh, Moosmann, Christian, Bernhardt, Markus, Keck, Jan, Flebbe, Hannah, Al-Bourini, Omar, Hosseini, Ali Seif Amir, Grade, Marian, Lorf, Thomas, Ghadimi, Michael, Perl, Thorsten, Gaedcke, Jochen

    Published in Biomedicines (01-01-2024)
    “…Postoperative liver failure (PLF) is a severe complication after major liver resection (MLR). To increase the safety of patients, clinical bedside tests are of…”
    Get full text
    Journal Article
  4. 4

    Altered regulation of Prox1-gene-expression in liver tumors by Dudas, Jozsef, Mansuroglu, Tümen, Moriconi, Federico, Haller, Florian, Wilting, Joerg, Lorf, Thomas, Füzesi, Laszlo, Ramadori, Giuliano

    Published in BMC cancer (09-04-2008)
    “…Prospero-related homeobox 1 (Prox1) transcription factor was described as a tumor-suppressor gene in liver tumors. In contrast, Prox1 knock out in murine…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Pattern of chromosomal aberrations in primary liver cancers identified by comparative genomic hybridization by Homayounfar, Kia, MD, Gunawan, Bastian, MD, Cameron, Silke, MD, Haller, Florian, MD, Baumhoer, Daniel, MD, Uecker, Stefan, MD, Sander, Bjoern, MD, Ramadori, Giuliano, MD, Lorf, Thomas, MD, Füzesi, László, MD

    Published in Human pathology (01-06-2009)
    “…Summary Little is known about the molecular cytogenetic changes in cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma, and on the prognostic…”
    Get full text
    Journal Article
  7. 7

    Pantoprazole Does not Affect Serum Trough Levels of Tacrolimus and Everolimus in Liver Transplant Recipients by Bremer, Sebastian C B, Reinhardt, Lars, Sobotta, Michael, Hasselluhn, Marie C, Lorf, Thomas, Ellenrieder, Volker, Schwörer, Harald

    Published in Frontiers in medicine (19-11-2018)
    “…Liver transplant recipients are frequently treated with proton pump inhibitors. Drug interactions have been described especially with respect to omeprazole…”
    Get full text
    Journal Article
  8. 8

    Posterior cavoplasty: a new approach to avoid venous outflow obstruction and symptoms for small-for-size syndrome in right lobe living donor liver transplantation by D Goralczyk, Armin, Obed, Aiman, Beham, Alexander, Tsui, Tung Yu, Lorf, Thomas

    Published in Langenbeck's archives of surgery (01-03-2011)
    “…Purpose A common and serious problem after living donor liver transplantation (LDLT) of small grafts is small-for-size syndrome (SFSS). Although hyperdynamic…”
    Get full text
    Journal Article
  9. 9

    Tissue damage with different surgical techniques in a porcine model of liver resection: implications for living-donor liver transplantation? by Goralczyk, Armin Dietmar, Obed, Aiman, große Beilage, Angelika, Sattler, Burckhardt, Füzesi, Laszlo, Lorf, Thomas

    “…Background/purpose For living-donor liver transplantation (LDLT) it is of paramount importance to preserve as much viable liver tissue as possible to avoid…”
    Get full text
    Journal Article
  10. 10

    A novel management strategy of steroid-free immunosuppression after liver transplantation : Efficacy and safety of tacrolimus and mycophenolate mofetil by RINGE, Burckhardt, BRAUN, Felix, SCHÜTZ, Ekkehard, FÜZESI, Lazlo, LORF, Thomas, CANELO, Ruben, OELLERICH, Michael, RAMADORI, Guiliano

    Published in Transplantation (27-02-2001)
    “…Corticosteroids have been used traditionally for immunosuppression after solid organ transplantation. The variety of modern immunosuppressive agents offers the…”
    Get full text
    Journal Article
  11. 11

    Patients without hepatocellular carcinoma progression after transarterial chemoembolization benefit from liver transplantation by Obed, Aiman, Beham, Alexander, Püllmann, Kerstin, Becker, Heinz, Schlitt, Hans J, Lorf, Thomas

    Published in World journal of gastroenterology : WJG (07-02-2007)
    “…AIM: To assess the outcome of patients, who underwent transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) and subsequently liver…”
    Get full text
    Journal Article
  12. 12

    Treatment of Hepatic Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Role of Liver Transplantation by Ringe, Burckhardt, Lorf, Thomas, Döpkens, Karen, Canelo, Ruben

    Published in World journal of surgery (01-06-2001)
    “… The role of liver transplantation in malignancy has been discussed, but controversially, over the past two decades. This is particularly true for hepatic…”
    Get full text
    Journal Article
  13. 13

    A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT by Goralczyk, Armin D, Schnitzbauer, Andreas, Tsui, Tung Y, Ramadori, Giuliano, Lorf, Thomas, Obed, Aiman

    Published in BMC surgery (09-04-2010)
    “…Immunosuppression with calcineurin inhibitors (CNI) increases the risk of renal dysfunction after orthotopic liver transplantation (OLT). Controlled trials…”
    Get full text
    Journal Article
  14. 14

    Role of the thymus in transplantation tolerance in miniature swine. I. Requirement of the thymus for rapid and stable induction of tolerance to class I-mismatched renal allografts by Yamada, K, Gianello, P R, Ierino, F L, Lorf, T, Shimizu, A, Meehan, S, Colvin, R B, Sachs, D H

    Published in The Journal of experimental medicine (18-08-1997)
    “…The almost uniform failure in transplant patients of tolerance-inducing regimens that have been found to be effective in rodents, has made it necessary to…”
    Get full text
    Journal Article
  15. 15

    Acute paranoid psychosis as sole clinical presentation of hepatic artery thrombosis after living donor liver transplantation by Goralczyk, Armin D, Meier, Volker, Ramadori, Giuliano, Obed, Aiman, Lorf, Thomas

    Published in BMC surgery (22-02-2010)
    “…Hepatic artery thrombosis is a devastating complication after orthotopic liver transplantation often requiring revascularization or re-transplantation. It is…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Liver transplantation for combined hepatocellular‐cholangiocarcinoma: Outcomes and prognostic factors for mortality. A multicenter analysis by Jaradat, Derar, Bagias, Georgios, Lorf, Thomas, Tokat, Yaman, Obed, Aiman, Oezcelik, Arzu

    Published in Clinical transplantation (01-02-2021)
    “…Introduction Combined hepatocellular‐cholangiocarcinoma is rare and comprises features of hepatocellular carcinoma and cholangiocarcinoma. The treatment of…”
    Get full text
    Journal Article
  20. 20

    Adult Living Donor Liver Transplantation with ABO-Incompatible Grafts: A German Single Center Experience by Goralczyk, Armin D., Obed, Aiman, Schnitzbauer, Andreas, Doenecke, Axel, Tsui, Tung Yu, Scherer, Marcus N., Ramadori, Giuliano, Lorf, Thomas

    Published in Journal of Transplantation (01-01-2009)
    “…Adult living donor liver transplantations (ALDLTs) across the ABO blood group barrier have been reported in Asia, North Americas, and Europe, but not yet in…”
    Get full text
    Journal Article